Exagen Inc is a medical technology company focused on the design, development and commercialization of diagnostic testing products under its AVISE brand. These products are used for the differential diagnosis, prognosis, and monitoring of rheumatic, autoimmune, and related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). The company operates in one operating segment. The majority of the company's revenue is derived from sales of its testing products.

What symbol and exchange does Exagen shares trade?

Exagen trades on the NASDAQ stock market under the symbol XGN.

What is Exagen stock price doing today?

As of November 12, 2026, XGN stock price declined to $4.95 with 60,160 million shares trading.

What is Exagen's Beta?

XGN has a beta of 3.47, meaning it tends to be more sensitive to market movements. XGN has a correlation of 0.20 to the broad based SPY ETF.

How much is Exagen worth?

XGN has a market cap of $119.50 million. This is considered a Micro Cap stock.

How much money does Exagen make?

Last quarter Exagen reported $18 million in Revenue and -$.25 earnings per share. This beat revenue expectation by $89,000 and missed earnings estimates by -$.08.

What is the highest and lowest price Exagen traded in the last 3 year period?

In the last 3 years, XGN traded as high as $12.23 and as low as $1.30.

What are the top ETFs holding Exagen?

The top ETF exchange traded funds that XGN belongs to (by Net Assets): VTI, VXF, IWC, BUSM, QQQS.

Is Exagen (XGN) a good investment?

XGN has underperformed the market in the last year with a price return of -46.3% while the SPY ETF gained +12.0%. XGN has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -26.9% and -41.1%, respectively, while the SPY returned -1.5% and -1.9%, respectively.

What are the support and resistance levels for Exagen (XGN)?

XGN support price is $4.75 and resistance is $5.32 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that XGN shares will trade within this expected range on the day.